Journal profile · Endocrinology & Metabolism
Steroids
ISSN 0039-128X · eISSN 1878-5867 · Elsevier Inc. · UNITED STATES · Monthly · Founded 1963
Steroids: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.73; hybrid open access; APC about USD 3,760; median 91 days to acceptance (97 articles, last 24 months); community-reported acceptance: easy; 102 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Steroids is published by Elsevier Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Estrogen and related hormone effects, Hormonal and reproductive studies and Steroid Chemistry and Biochemistry, together about 42.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
STEROIDS is an international research journal devoted to studies on all chemical and biological aspects of steroidal moieties. The journal focuses on both experimental and theoretical studies on the biology, chemistry, biosynthesis, metabolism, molecular biology, physiology and pharmacology of steroids and other molecules that target or regulate steroid receptors. Manuscripts presenting clinical research related to steroids, steroid drug development, comparative endocrinology of steroid hormones, investigations on the mechanism of steroid action and steroid chemistry are all appropriate for submission for peer review. STEROIDS publishes both original research and timely reviews. For details concerning the preparation of manuscripts see Instructions to Authors, which is published in each issue of the journal.
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Editor-in-chief Trevor M. PenningPublisher website
Editorial board by country: 2 in mainland China (about 4%); most named United States 27, South Africa 5, Canada 4, Mainland China 2, United Kingdom 2 (54 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Estrogen and related hormone effectsBiochemistry, Genetics and Molecular Biology19.6%
- Hormonal and reproductive studiesMedicine13.1%
- Steroid Chemistry and BiochemistryBiochemistry, Genetics and Molecular Biology10.1%
- Hormonal Regulation and HypertensionMedicine7.9%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics4%
- Analytical Chemistry and ChromatographyChemistry3.7%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance3.1%
- Human auditory perception and evaluationEngineering2.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.73LetPub ·
- Impact factor (publisher)
- 2.7Publisher website ·
- CiteScore 2026-06
- 4.8LetPub ·
- CiteScore (publisher)
- 4.8Publisher website ·
- SJR 2026-06
- 0.63LetPub ·
- SNIP 2026-06
- 0.77LetPub ·
- h-index
- 95LetPub ·
- h-index
- 153OpenAlex ·
- i10-index
- 5,122OpenAlex ·
- 2-year mean citedness
- 2.68OpenAlex ·
- Self-citation rate
- 3.7%LetPub ·
- Share of gold OA articles
- 18.66%LetPub ·
Volume
- Articles per year
- 85LetPub ·
Articles by year OpenAlex count · 9,183 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 70 | 14 | 14 |
| 2025 | 102 | 24 | 161 |
| 2024 | 114 | 36 | 592 |
| 2023 | 114 | 30 | 907 |
| 2022 | 137 | 28 | 1,088 |
| 2021 | 90 | 13 | 975 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
91 daysMedian, submission to acceptance · P25–P75 62 days – 113 days
- Acceptance to online
- median 2 days (97 articles)
- Submission to online
- median 94 days
- Sample
- 97 articles with submission and acceptance dates (194 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 2 daysPublisher website ·
- First decision after review
- 37 daysPublisher website ·
- Submission to acceptance
- 80 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,760 / EUR 3,520 / GBP 3,010 / JPY 466,350 | — | — | |
| Publisher website | USD 3,740 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- Numbered, in order of citation
- Highlights
- Required
- Graphical abstract
- Optional
Article types accepted7
- letter to the editorLetters to the Editor are welcome, for editing and publication at the discretion of the editor.Length not stated
- letters to the editorSignificant original research papers and pertinent reviews on all aspects of steroids will be considered for publication. Specifically, both experimental and th…Length not stated
- original research paperArticle typesSignificant original research papers and pertinent reviews on all aspects of steroids will be considered for publication. Specifically, both experi…Length not stated
- rapid communicationArticle typesSignificant original research papers and pertinent reviews on all aspects of steroids will be considered for publication. Specifically, both experi…Length not stated
- research paperSignificant original research papers and pertinent reviews on all aspects of steroids will be considered for publication.Length not stated
- reviewArticle typesSignificant original research papers and pertinent reviews on all aspects of steroids will be considered for publication. Specifically, both experi…Length not stated
- review articleArticle typesSignificant original research papers and pertinent reviews on all aspects of steroids will be considered for publication. Specifically, both experi…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1963
- ISSN
- 0039-128X
- Electronic ISSN
- 1878-5867
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Steroids
What CAS zone is Steroids in?
In the 2025 upgraded edition of the CAS Journal Ranking, Steroids is in Zone 4 of Medicine, and in Zone 4 of the minor category Biochemistry & Molecular Biology / Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Steroids?
The latest impact factor listed by LetPub is 2.73; CiteScore 4.8, h-index 153.
How long does peer review take at Steroids?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 91 days (interquartile range 62–113 days); authors report an average review time of about 2 months; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Steroids?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Numbered, in order of citation; Highlights: Required; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Steroids based?
Of the 54 board members whose country the journal's board page names, 2 (about 4%) are in mainland China; the countries named most often are United States (27), South Africa (5) and Canada (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Steroids?
According to LetPub and DOAJ records, Steroids is indexed in SCIE and Scopus.
Is Steroids open access, and what is the APC?
Steroids is a hybrid journal. For open-access publication: APC about USD 3,760.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .